Department of Pain Management, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
Jiangsu Province Key Laboratory of Anesthesiology and Analgesia Application Technology, Xuzhou Medical University, Xuzhou 221004, China.
Pain Res Manag. 2020 Dec 1;2020:8857287. doi: 10.1155/2020/8857287. eCollection 2020.
Herpes zoster (HZ) is an acute inflammatory neurocutaneous disease caused by the reactivation of varicella-zoster virus. It is estimated that the incidence of postherpetic neuralgia following HZ is 10-20%. The leading risk factors of the prognosis are aging and immunity dysfunction. Vitamin C plays a pivoted role in enhancing white blood cell function. Epidemiological evidence and clinical studies have indicated an association between pain and suboptimal vitamin C status. At present, vitamin C has been used as an additional option in the treatment of HZ-associated pain. Despite the current controversy, case reports and randomized controlled studies have indicated that both acute- and postherpetic neuralgia can be dramatically alleviated following intravenous vitamin C infusions. . Two patients (male aged 72 and female 78 years) with HZ did not respond well to antiviral therapy and analgesics. Skin lesions in the right groin and front thigh healed after early antiviral therapy, but the outbreak of pain persisted in the male patient. The female patient presented to our clinic with clusters of rashes in the right forehead with severe edema of her right upper eyelid. Because nerve blockade could not be conducted for both patients, intravenous infusion of vitamin C was applied and resulted in an immediate remission of the breakthrough pain in the male patient and cutaneous lesions in the female patient.
The use of vitamin C appears to be an emerging treatment alternative for attenuating HZ and PHN pain. Hence, we recommend the addition of concomitant use of intravenously administered vitamin C into therapeutic strategies in the treatment of HZ-associated pain, especially for therapy-resistant cases. Furthermore, animal studies are required to determine analgesic mechanisms of vitamin C, and more randomized clinical trials are essential to further determine the optimal dose and timing of administration of vitamin C.
带状疱疹(HZ)是由水痘-带状疱疹病毒再激活引起的急性炎症性神经皮肤疾病。据估计,HZ 后发生带状疱疹后神经痛的发病率为 10-20%。预后的主要危险因素是衰老和免疫功能障碍。维生素 C 在增强白细胞功能方面起着关键作用。流行病学证据和临床研究表明疼痛与维生素 C 状态不佳有关。目前,维生素 C 已被用作治疗 HZ 相关疼痛的附加选择。尽管目前存在争议,但病例报告和随机对照研究表明,静脉注射维生素 C 可显著缓解急性和带状疱疹后神经痛。。两名 HZ 患者(男性 72 岁,女性 78 岁)对抗病毒治疗和镇痛药物反应不佳。早期抗病毒治疗后,右侧腹股沟和大腿前部的皮损愈合,但男性患者的疼痛持续发作。女性患者因右额皮疹簇集伴右眼上睑严重肿胀就诊于我院。由于两名患者均不能进行神经阻滞,故给予静脉注射维生素 C,结果男性患者的爆发性疼痛立即缓解,女性患者的皮疹也消退。
维生素 C 的使用似乎是一种治疗 HZ 和 PHN 疼痛的新兴替代方法。因此,我们建议在治疗 HZ 相关疼痛的治疗策略中加入静脉给予维生素 C 的辅助治疗,尤其是对于治疗抵抗的病例。此外,还需要进行动物研究以确定维生素 C 的镇痛机制,并且需要更多的随机临床试验来进一步确定维生素 C 的最佳剂量和给药时间。